Subcortical Brain Morphology in Schizophrenia : Descriptive analysis based on MRI findings of subcortical brain volumes
- Published: 01 Jan 2009
1. Andreasen NC. Schizophrenia: the fundamental questions. Brain Res Brain Res Rev 31: 106-12, 2000.
2. Smith TE, Weston CA, Lieberman JA. Schizophrenia (maintenance treatment). Clin Evid (Online ) 2009: 2009.
3. WHO. International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10). World Health Organization . 2007. URL: http://apps.who.int/classifications/apps/icd/icd10online/
4. Tamminga CA, Holcomb HH. Phenotype of schizophrenia: a review and formulation. Mol Psychiatry 10: 27-39, 2005.
5. Cardno AG, Gottesman II. Twin studies of schizophrenia: from bow-andarrow concordances to star wars Mx and functional genomics. Am J Med Genet 97: 12-7, 2000.
6. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60: 1187- 92, 2003.
7. McGrath JJ. Variations in the incidence of schizophrenia: data versus dogma. Schizophr Bull 32: 195-7, 2006.
8. Harrison G, Fouskakis D, Rasmussen F, Tynelius P, Sipos A, Gunnell D. Association between psychotic disorder and urban place of birth is not mediated by obstetric complications or childhood socio-economic position: a cohort study. Psychol Med 33: 723-31, 2003.
9. Lim C, Chong SA, Keefe RS. Psychosocial factors in the neurobiology of schizophrenia: a selective review. Ann Acad Med Singapore 38: 402-6, 2009.
10. Torrey EF, Buka S, Cannon TD, Goldstein JM, Seidman LJ, Liu T, Hadley T, Rosso IM, Bearden C, Yolken RH. Paternal age as a risk factor for schizophrenia: how important is it? Schizophr Res 2009.
11. Lieberman JA. Antipsychotic drugs- comparison in animal models of efficacy neurotransmitter regulation and neuroprotection. Pharmacol Rev 60: 358-403, 2008.
12. van Os J, Kapur S. Schizophrenia. Lancet 374: 635-45, 2009.
13. Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, Radue EW, McGuire PK, Riecher-Rossler A, Borgwardt SJ. The effects of
14. Meltzer HY, Huang M. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems. Prog Brain Res 172: 177-97, 2008.
15. McCarley RW, Wible CG, Frumin M, Hirayasu Y, Levitt JJ, Fischer IA, Shenton ME. MRI anatomy of schizophrenia. Biol Psychiatry 45: 1099-119, 1999. [OpenAIRE]